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Introduction
The nasal valve area is the narrowest passage in the
upper respiratory tract, causing more than half of the total
resistance to nasal respiration in healthy subjects.1 The pro-
portional ratio between the cross-section area of the nasal
valve and the bony piriform aperture is approximately
1:1.4.2 The cross-section area on each side of the nasal valve
is approximately 30 mm, in the middle of the nasal cavi-
ty120 mm, and in the nasopharynx 150mm.  
A nasal dilator  Nosovent3 is a device to fit in the
nasal cavity. It has two prongs and one stem. It is based on
Thudiculum nasal speculum shape. The prongs fit in the
nasal vestibule and stem keeps them away due to its shape
and power and it causes dilatation of anterior nares. It is
made of silastic, which is non-irritant and easy to wash and
is reusable. Its texture maintains its elasticity for more than
6 months. It is available in three sizes; small, medium and
large. Medium is the most widely used (nearly 60%), how-
ever a very few (10%) need the small, while the remainder
use the large size. It is a mechanical method to keep nasal
valve area dilated and is well tolerated by males and less by
females due to use of "coca" in the nasal alae and also for
cosmetic reasons.
Anatomic Orientation and Ethnic Variations
Migration of people and military conquests has
resulted in an admixture of ethnic groups and the interaction
of genetic factors. Thus, there are innumerable variations of
nasal structural characteristics. Wen4 studied the ontogeny
and phylogeny of nasal cartilages in primates and in man.
He noted structural differences in the nasal cartilages of
black and white individuals. 
From a clinical standpoint nasal vestibules are differ-
ent in Caucasians, Orientals and Negroid. Of the three major
races, the variation in nasal form is greatest within the
Caucasian race. Rogers5,6 defined the following types of
nose:
1. Nordic: convex profile, narrow radix, sharp tip, and nar-
row nostrils and alae.
2. East Baltic: less narrow than the nordic nose, less dorsal
convexity, thicker alar cartilages, and broader tip.
3. Alpine (Central and Eastern Europe): a more concave
and foreshortened nose, and medium sized tip.
4. Dinaric (Balkan): large and long nose with drooping tip.
5. Armenoid (Middle East): large, convex noses with great
height and length and wide tip. The large alar cartilages
curve posteriorly and expose the inner aspect of the col-
umella on profile view.
6. Mediterranean (Italy, Spain): straight or convex dor-
sum with thin radix and tip.
The Pakistani people have nasal shape comparable to East
Baltic group.
Patients and Methods
One hundred subjects were selected by non-proba-
bility purposive sampling from the out patient department
of Sir Ganga Ram Hospital, Lahore. There were 60 males
and 40 females, having age ranging from 18 to 75 years. 
Inclusion criteria
All the patients having complaints of nasal obstruc-
tion, due to allergic rhinitis, vasomotor rhinitis, congestion
during pregnancy and menstruation, common cold and trau-
matic nose were included in the study (Table 1).
Exclusion criteria
Patients below 18 years of age, having marked sep-
tal deviation, nasal polyposis, malignancy, vestibulitis, per-
sonality disorder and patients suffering from asthma or
Original Article
Clinical study on the use of Nozovent in a tertiary care setting
M. Sohail Awan, M. Mubarik Ali, Manzoor Ahmed, Asim Iqbal, M. Javed Aslam*
Otolaryngology - Head and Neck Surgery, Department of Surgery, The Aga Khan University Hospital, Karachi and Sir Ganga Ram Hospital*, Lahore.
Abstract
Objective: To assess the effectiveness of the Nozovent device in Pakistani subjects at Aga Khan University
Hospital, Karachi and Sir Ganga Ram Hospital, Lahore from 15 January 2001 to 15 January 2002.
Methods: Sixty males and 40 females were selected by non probability purposive sampling, from OPD of ENT
Department, complaining of nasal obstruction due to various reasons, e.g. vasomotor rhinitis, allergic rhinitis,
congestion during pregnancy and menstruation, common cold, traumatic nose and nasal valve problem.
Results: All patients benefited subjectively but the degree of relief varied in individuals.
Conclusion: The Nozovent provides a unique method to relieve nasal obstruction with no side effects (JPMA
54:614;2004).
deviation, nasal polyposis, malignancy, vestibulitis,
personality disorder and patients suffering from asthma or
chest problems were excluded from study.
All patients had complaints of mouth breathing dur-
ing the phase of nasal obstruction. The nose was examined
for airflow and level of obstruction. The treating physician
filled a performa explaining patient's complaints and symp-
toms. After full assessment of the anterior nares, Nosovent
was prescribed and patients were educated how to use it.
Most of the patients used it at night, as the main complaint
was nasal obstruction and snoring at night when they were
asleep. Patients were assessed once a week during first
month, twice a week for next two months and every month
thereafter. After this follow up patients were advised to use
the device whenever they felt nasal obstruction throughout
their life. The patients were observed subjectively by scor-
ing system, rating 0 to 100. The response was graded as
Grade I; 75% -100% relief of symptoms, Grade II; 50%-
75% response, Grade III; <50% response.
Results
Of the hundred subjects included in the study, 46
patients had nasal obstruction due to vasomotor rhinitis, 24
had obstruction due to allergic rhinitis, 16 patients suffered
obstructed nose due to trauma, 08 had congested nose dur-
ing pregnancy and menstruation, and 06 patients had nasal
obstruction during frequent colds. Of these patients, 26
patients snored due to nasal obstruction. Patients were
examined at follow up weekly clinics during 1st month,
twice a month for 2 months and then every month for 3
months. The response was Grade I in 80 patients out of 100
(80%), Grade II in 6 patients, making 6% and Grade III in
remaining 14 patients (14%) (Table 2). All male patients
who were included in the study used the device (Nozovent)
and benefited from Nozovent in the range of 30% to 80%.
Male patients were followed regularly in the out patient
department. Out of 40 females, 4 refused to use the device;
one due to mild pain and other three due to the fear of dila-
tion of their nostrils. Three more female patients had prob-
lems, because they did not want to remove the 'cocca'.
Thirty seven out of 40 females used it regularly, and bene-
fited subjectively in range of 30% to 60%. No major com-
plications were reported, except 40 patients (40%) who
complained of irritation, epiphora and sneezing during first
48 to 72 hours. Most of the patients got adapted to the
Nosovent like using the wrist watch. 
Patients who were diagnosed, as vasomotor rhinitis,
had very good response. Thirty eight patients out of 46 got
benefit upto 80% (Grade I). These patients used Nosovent
for 8 -10 hours daily at night. Twenty patients reported that
their airway remained patent for whole day. Six patients out
of 46 had to use an anxiolytic, (Lexotanil) for one month.
Twelve patients used Nozovent only for 2-3 hours daily and
found that their nose remained patent the whole day.
All patients with snoring due to nasal obstruction got
benefit (Grade I) except one patient who was advised to
reduce weight and later had uvulopalatopharyngoplasty
(UPPP). 
All patients (24) with allergic rhinitis continued to
use anti-histamine for six weeks. Eighteen patients with
allergic rhinitis had Grade I response and 6 had Grade II
response. Two patients had to use Inj. Depomedrol intra-
muscularly once to suppress  rhinorrhoea.
Patients who had nasal airway problems due to trau-
ma were the best candidates. All patients in our study had
alar collapse and retracted collumella. These patients had to
use Nozovent for a longer duration and most of the time
once in 24 hours.
Six patients out of 100 used it during common cold. No
doubt they got relief from nasal obstruction but complained of
difficulty in using the device due to hypersensitivity and rhin-
orrhoea. These patients had rhinorrhoea and sneezing while
using Nozovent and  5 out of 6 abandoned it. One patient
who was above 50 years tolerated it well.
Table 1. Indications for use of Nozovent (n = 100).
Pathology No. of patients
Vasomotor Rhinitis 
46
Allergic Rhinitis 
24
Traumatic / Post-op surgery 16
Congestion during pregnancy and menstruation 8
Common cold 6
Table 2. Results (n =100).
Total Grade I Grade II Grade III
Vasomotor rhinitis 46 38 0 8
Allergic rhinitis 24 18 6 0
Trauma 16 16 0 0
Congestion during pregnancy 
and menstruation 8 8 0 0
Common cold 6 0 0 6
Discussion
Patients complaining of a blocked nose are an
extremely common presentation in any ENT clinic. Nasal
obstruction can be due to variety of reasons, congenital or
acquired. Acquired causes are allergic rhinitis, vasomotor
rhinitis, congestion during pregnancy and menstruation,
trauma etc. The narrowest part of the respiratory tract is the
nose. In the nose major portion of nasal airway resistance is
localized to the nasal valve area.7 Nasal valve area is bound-
ed: medially by the septum; superiorly and laterally by the
caudal margin of the upper lateral cartilage and its fibro-adi-
pose attachment to the piriform aperture and inferiorly by
the floor of the pyriform aperture. At rest, approximately 50
- 60% of airflow resistance of the entire respiratory tract, is
located in the nasal cavity.8 Approximately one-third of the
resistance lies in the compliant nasal vestibule region and
two-thirds at the level of the nasal valve area. Because the
degree of obstruction to airflow is inversely and exponen-
tially related to cross-sectional area of the nasal lumen, dis-
placement of either wall of the valve by as little as 1 mm can
result in large changes in resistance. Air flow velocity
increases as diameter decreases, and turbulent flow is more
likely to be present in high velocity flow. Increasing the
diameter of limiting segment should therefore increase the
proportion of laminar flow. Turbulent flow as we know
causes generation of higher resistance. More over dynamic
collapse of nasal valve occurs at higher flow rates increas-
ing flow resistance.9-11
The Francis alae nasi prop was probably the first
nasal dilator used for the relief of nasal obstruction in the
nasal valve area. Other internal metal devices have also
been used for relief of nasal obstruction at nasal valve area. 
Nosovent is a device made of medical-grade plastic.
It has two prongs which when inserted in the nostrils keep
them apart due to elasticity of the material. The mechanism
of action of nasal dilator Nozovent is simple and is similar
to the Cottle test.12 When the nostrils are dilated with
Nozovent the airflow through the nose is increased.13,14 This
produces a significant reduction in nasal resistance to respi-
ratory airflow.15 This improvement in airflow is comparable
with that observed when nasal drops are used for deconges-
tion of nasal mucosa in healthy subjects.16
The effect of Nozovent has been tested in normal
subjects and snorers. In one study mechanical nasal dilata-
tion caused significantly greater increase in cross sectional
area of nose as compared to that achieved with nasal decon-
gestion alone.17
We used this device in hundred subjects, 60 males
and 40 females. The response was better in males up to 80%
as compared to females where it was 60%. This is due to the
fact that males were more compliant in using the device as
compared to females. 
Most of the patients were having nasal obstruction
due to vasomotor rhinitis VMR (n = 46). Nasal obstruction
in VMR, allergic rhinitis and common cold is due to
turbinate hypertrophy and mucosal oedema. Similarly in
pregnancy and during menstruation there is nasal congestion
due to mucosal oedema and turbinate hypertrophy. As the
nasal airflow is increased the turbinate shrink, sinus ventila-
tion is improved leading to decrease in consequences of
mucosal oedema and hypertrophy. More over Nosovent
involves no risk of side effects and drug interactions and is
effective in improving nasal breathing. Therefore Nosovent
is very effective in treating nasal obstruction due to turbinate
hypertrophy and mucosal edema without drugs related side
effects as in pregnancy.18,19
Snoring is a sound made by vibrations of soft tissues
in upper airway. It is caused by partial blockage of upper
airway. When patient is awake sufficient muscle tone is
present to keep airway open. When asleep, this muscle tone
is lost and airway narrows.10,20 As air passes through a par-
tially obstructed airway, its velocity increases and this pro-
duces turbulence while passing through lax tissues in the
upper airway. If the nostrils are opened up with Nozovent,
the air will pass more easily through the upper airways caus-
ing minimal vibration and little or no snoring. In our study
26 patients had complaints of snoring due to nasal obstruc-
tion. In these patients' nasal obstruction as well as snoring
was improved with Nosovent.
Patients with narrowing of the nasal valve area were
the best candidates. In our study patients with traumatic alar
collapse benefited fully from nasal dilatation with Nosovent.
Mechanical dilatation of nose by Nosovent is a
unique method to relieve nasal obstruction. Its use increases
nasal airflow by 50%, thus improves nasal breathing, and
prevents mouth breathing and its consequences. In selected
cases of snoring due to nasal causes, it improves snoring.
Moreover it is without risks and side effects of medications
and can be used when medicinal treatment is contraindicat-
ed as in cardiovascular diseases and during pregnancy.
Although females are reluctant in using it but no doubt it is
an effective way to treat nasal obstruction due to various rea-
sons.
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specimens were expelled onto two or three slides, and thin
